Zydus Lifesciences Ltd.
|
HALFYEARLY RESULTS
|
|
You can view the
Halfyearly Results
for the last 5 years.
Market Cap. (Rs.)
|
95848.82 Cr.
|
P/BV
|
5.47
|
Book Value (Rs.)
|
174.07
|
52 Week High/Low (Rs.)
|
1032/485
|
FV/ML
|
1/1
|
P/E(X)
|
48.90
|
Bookclosure
|
28/07/2023
|
EPS (Rs.)
|
19.48
|
Div Yield (%)
|
0.63
|
|
(Rs. in Crs.)
Net Sales/Income from operations | 9508.40 | 9214.80 | 7865.50 | 7396.80 | 7810.20 |
Other Operating Income | 0.00 | 158.10 | 341.90 | 122.00 | 0.00 |
Total Income From Operations | 9508.40 | 9372.90 | 8207.40 | 7518.80 | 7810.20 |
| | | | | |
EXPENDITURE | | | | | |
Consumption of Raw Materials | 2307.00 | 2144.20 | 1978.40 | 2000.60 | 2097.30 |
Purchase of Traded Goods | 895.60 | 946.70 | 1002.70 | 1001.40 | 863.20 |
Increase/Decrease in Stocks | -54.40 | 115.50 | 122.60 | -158.90 | -203.40 |
Employees Cost | 1483.30 | 1412.90 | 1352.70 | 1185.30 | 1301.90 |
Depreciation | 364.00 | 360.20 | 362.50 | 368.60 | 367.50 |
Other Expenses | 2225.50 | 2542.00 | 2102.70 | 2020.20 | 1957.40 |
Total Expenses | 7221.00 | 7521.50 | 6921.60 | 6417.20 | 6383.90 |
| | | | | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 2287.40 | 1851.40 | 1285.80 | 1101.60 | 1426.30 |
Other Income | 90.00 | 76.30 | 110.30 | 139.90 | 84.90 |
P/L Before Interest, Excpt. Items & Tax | 2377.40 | 1927.70 | 1396.10 | 1241.50 | 1511.20 |
Interest | 26.80 | 60.50 | 69.40 | 69.60 | 57.40 |
P/L Before Exceptional Items & Tax | 2350.60 | 1867.20 | 1326.70 | 1171.90 | 1453.80 |
Exceptional Items | -14.20 | -601.30 | -2.90 | 0.00 | -95.70 |
P/L Before Tax | 2336.40 | 1265.90 | 1323.80 | 1171.90 | 1358.10 |
Tax | 442.50 | 332.40 | 255.40 | 219.90 | 241.50 |
P/L After Tax from Ordinary Activities | 1893.90 | 933.50 | 1068.40 | 952.00 | 1116.60 |
Extra Ordinary Item | -2.00 | -1.80 | -2.80 | -15.00 | 2518.50 |
Net Profit/Loss For the Period | 1891.90 | 931.70 | 1065.60 | 937.00 | 3635.10 |
Minority Interest | -49.20 | -69.90 | -61.70 | -66.10 | -64.90 |
Share Of P/L Of Associates | 44.90 | 57.70 | 36.90 | 26.90 | 19.30 |
Net P/L After Minority Interest & Share Of Associates | 1887.60 | 919.50 | 1040.80 | 897.80 | 3589.50 |
| | | | | |
Equity Share Capital | 101.20 | 101.20 | 101.20 | 102.40 | 102.40 |
EPS Before Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 18.65 | 9.21 | 10.21 | 9.15 | 35.06 |
Diluted EPS (Rs.) | 18.65 | 9.22 | 10.21 | 9.30 | 35.06 |
EPS After Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 18.65 | 9.21 | 10.53 | 9.15 | 35.06 |
Diluted EPS (Rs.) | 18.65 | 9.09 | 10.21 | 8.77 | 35.06 |
| | | | | |
PBITOE Margin (%) | 24.05 | 19.75 | 15.66 | 14.65 | 18.26 |
PBTE Margin (%) | 24.72 | 19.92 | 16.16 | 15.58 | 18.61 |
PBT Margin (%) | 24.57 | 13.50 | 16.12 | 15.58 | 17.38 |
PAT Margin (%) | 19.89 | 9.94 | 12.98 | 12.46 | 46.54 |
PAT After MI And SOA Margin (%) | 19.85 | 9.81 | 12.68 | 11.94 | 45.95 |